Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 76 AL 90

The treatment of Alzheimer's disease using Chinese medicinal plants: from disease models to potential clinical applications

Su Y, Wang Q, Wang C, Chan K, Sun Y, Kuang H.

J Ethnopharmacol. 2014 Mar 28;152(3):403-23. doi: 10.1016/j.jep.2013.12.053. Epub 2014 Jan 9.

Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease

Sharma A, Bemis M, Desilets AR.

Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):409-14. doi: 10.1177/1533317513518650. Epub 2014 Jan 9.

Time course of brain volume changes in the preclinical phase of Alzheimer's disease

Bernard C, Helmer C, Dilharreguy B, Amieva H, Auriacombe S, Dartigues JF, Allard M, Catheline G.

Alzheimers Dement. 2014 Mar;10(2):143-151.e1. doi: 10.1016/j.jalz.2013.08.279. Epub 2014 Jan 10.

Efficacy and safety evaluation of HSD-1 inhibitor ABT-384 in Alzheimer's disease

Marek GJ, Katz DA, Meier A, Greco N 4th, Zhang W, Liu W, Lenz RA.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S364-73. doi: 10.1016/j.jalz.2013.09.010. Epub 2014 Jan 10.

Brain sex matters: estrogen in cognition and Alzheimer's disease

Li R, Cui J, Shen Y.

Mol Cell Endocrinol. 2014 May 25;389(1-2):13-21. doi: 10.1016/j.mce.2013.12.018. Epub 2014 Jan 11.

Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles

Iqbal K, Liu F, Gong CX.

Biochem Pharmacol. 2014 Apr 15;88(4):631-9. doi: 10.1016/j.bcp.2014.01.002. Epub 2014 Jan 10.

γ-Secretase modulators: current status and future directions

Hall A, Patel TR.

Prog Med Chem. 2014;53:101-45. doi: 10.1016/B978-0-444-63380-4.00003-2.

[Cellular models for individualized medicine in Alzheimer's disease using patient-derived induced pluripotent stem cells]

Asai M, Shirotani K, Kondo T, Inoue H, Iwata N.

Nihon Yakurigaku Zasshi. 2014 Jan;143(1):23-6. doi: 10.1254/fpj.143.23.

Effect of TTP488 in patients with mild to moderate Alzheimer's disease

Burstein AH, Grimes I, Galasko DR, Aisen PS, Sabbagh M, Mjalli AM.

BMC Neurol. 2014 Jan 15;14:12. doi: 10.1186/1471-2377-14-12.

Therapeutic implications of the prostaglandin pathway in Alzheimer's disease

Cudaback E, Jorstad NL, Yang Y, Montine TJ, Keene CD.

Biochem Pharmacol. 2014 Apr 15;88(4):565-72. doi: 10.1016/j.bcp.2013.12.014. Epub 2014 Jan 13.

Early psychosocial intervention in Alzheimer's disease: cost utility evaluation alongside the Danish Alzheimer's Intervention Study (DAISY)

Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Phung KT, Waldemar G; DAISY Study Investigators.

BMJ Open. 2014 Jan 15;4(1):e004105. doi: 10.1136/bmjopen-2013-004105.

The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area

Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, Limoa E, Liaury K, Hashioka S, Murotani K, Horiguchi J.

Int J Geriatr Psychiatry. 2014 Sep;29(9):881-9. doi: 10.1002/gps.4074. Epub 2014 Jan 17.

Review: The genetics of Alzheimer's disease; putting flesh on the bones

Medway C, Morgan K.

Neuropathol Appl Neurobiol. 2014 Feb;40(2):97-105. doi: 10.1111/nan.12101.

Microglial dysfunction in brain aging and Alzheimer's disease

Mosher KI, Wyss-Coray T.

Biochem Pharmacol. 2014 Apr 15;88(4):594-604. doi: 10.1016/j.bcp.2014.01.008. Epub 2014 Jan 18.

Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?

Panza F, Logroscino G, Imbimbo BP, Solfrizzi V.

Curr Opin Psychiatry. 2014 Mar;27(2):128-37. doi: 10.1097/YCO.0000000000000041.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias